Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relamorelin in Diabetic Gastroparesis
NCT03285308Phase 3Terminated
- Sponsor
- Allergan
- Start
- Sep 2017
- Primary completion
- Jul 2020
- Modality
- Peptides, Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of relamorelin in diabetic gastroparesis, sponsored by Allergan. Started Sep 2017; status: terminated.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT03285308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03285308.